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We observed ﬁbrillation, loss of proteoglycan and cluster formation
in OA cartilage. Expression of MMP -1, 3 and uPAR was widely
detected. C2C was co-localized with these enzymes especially in
the superﬁcial zone of OA lesion. Interestingly, both TLR 2 and 4
were abundantly expressed in the OA lesion and co-localized with
MMPs and C2C.
As TLR-2 was expressed in normal cartilage, but not TLR-4, there
is the possibility that initially TLR-2 is important for chondrocyte to
recognized the osteoarthritic condition. In addition, it is reported
that TLR-2 can be regulated by IL-1 and ﬁbronectin fragments.
Secondary, induced TRL-4 could have important role on the further
catabolic response of chondrocyte.
Conclusions: It is important to study the degradative enzymes in
including MMPs and serine proteinases such as uPA and speciﬁc
degradative products by those enzymes together because the ac-
tivation mechanism of enzymes was very complicated. We demon-
strated these degradative process of cartilage matrix could be re-
lated to the expression TLR-2 and 4. The innate immunoresponse
through TLRs could have important roles on development of OA.
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ROTENONE TREATMENT IMPAIRS BIOSYNTHETIC
ACTIVITY IN ARTICULAR CARTILAGE
M.W. Walter, A.E. Martini, T.O. McKinley, J.A. Martin
The Univ. of Iowa, Iowa City, IA
Purpose: It has been reported that loss of mitochondria from
articular cartilage chondrocytes is involved in the pathogenesis
of osteoarthritis (OA). Reduced mitochondrial function is believed
to promote cartilage degeneration by undercutting biosynthetic
activity, but direct evidence of this relationship is lacking. To test
this hypothesis we determined the effects of rotenone, an inhibitor
of complex I of the mitochondrial electron transport chain, on
protein biosynthesis and matrix stability in bovine osteochondral
explants.
Methods: Tissue. Osteochondral explants were harvested from
bovine lateral tibial plateaus and incubated in culture medium with
10% serum.
Rotenone Treatment. Samples were treated daily for 7 days with
2.5 μm rotenone.
Mitochondrial Activity. Explants were stained with calcein AM and
Mitotracker Deep Red FM (Invitrogen) for 1 hour each prior to
imaging. Confocal microscopy was used to obtain Z-series images
(0 to ∼200 μm deep in 20 μm intervals), which were projected and
analyzed with ImageJ software. Numbers of live cells (calcein AM)
and cells containing functional mitochondria (Mitotracker) were
measured and ratios of Mitotracker positive cells to Calcein AM
positive cells were calculated for each image.
DNA and Proteoglycan Content. The DNA and proteoglycan con-
tent were assayed by standard methods following Papain digestion
and normalized to the wet weight of the samples (ng DNA/mg tis-
sue and μg GAG/mg tissue).
Biosynthetic Activity. Protein synthesis was analyzed by measuring
3H-Proline incorporation after 18 hours of radiolabeling. The re-
sults were normalized to the wet weight of the samples (CPM/mg
tissue).
Statistical Analysis. Statistical analysis was performed using Stu-
dent’s t-tests (p < 0.05).
Results: Rotenone signiﬁcantly reduced Mitotracker staining in the
superﬁcial and middle zones (Figure 1). 3H-proline incorporation
was also signiﬁcantly inhibited by rotenone treatment (Figure 2).
DNA content was signiﬁcantly reduced by rotenone treatment
(Figure 3), but no signiﬁcant effect on proteoglycan content was
observed (Figure 4).
Conclusions: Rotenone signiﬁcantly inhibited mitochondrial func-
tion and suppressed biosynthetic activity. The DNA content of
Figure 1. Rotenone treatment signiﬁcantly reduced mitochondrial activity in
chondrocytes in the superﬁcial (<200 μm deep) and middle (400–200 μm deep)
zones, but not in the deep zone (>400 μm deep).
Figure 2. Rotenone treatment signiﬁcantly reduced tritiated proline incorpora-
tion.
Figure 3. Rotenone treatment signiﬁcantly reduced DNA content.
Figure 4. Rotenone treatment had no signiﬁcant effect on glycosaminoglycan
(GAG) content.
rotenone-treated explants was also reduced, indicating cell death.
DNA content was reduced 1.6-fold whereas biosynthetic activity
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declined 2.3-fold, suggesting that metabolic suppression as well
as cell losses contributed to the inhibitory effect of rotenone on
overall biosynthetic activity. Although there was no change in pro-
teoglycan content attributable to rotenone treatment, it is possible
that proteoglycan depletion may have been detectable with longer
culture times. These ﬁndings support the hypothesis that chronic
suppression of mitochondrial activity inhibits protein synthesis.
However, it is still unclear if these effects lead to cartilage matrix
instability.
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INTRODUCING A NEW EX VIVO MODEL FOR
OSTEOARTHRITIS INCLUDES DIFFERENT
SUBPOPULATIONOF ARTICULAR CHONDROCYTES
PHENOTYPE AS WELL AS CALCIFIED CARTILAGE AND
SUBCHONDRAL BONE
P. Chen, K. Henriksen, S.H. Madsen, B.C. Søndergaard,
M.A. Karsdal, A.-C. Bay-Jensen
NordicbioSci. A/S, Herlev, Denmark
Purpose: The pathogenesis of osteoarthritis (OA) is a chronic
process, which include cartilage loss and abnormal differentiation
of chondrocytes. The objective of this study was to develop and
validate a novel ex vivo model for OA, which includes different
chondrocyte phenotypes, as well as the cells of the calciﬁed
cartilage and the subchondral bone. We propose to use this
model to investigate whole tissue pathobiology including cartilage
turnover, cellular interactions between different subpopulations of
chondrycytes, osteoblast and osteoclast upon stimulation with
catabolic and anabolic factors (e.g. proinﬂammatory cytokines and
potentially drug candidates).
Methods: Explant cultures Full depth cartilage explants were
isolated from bovine femoral condyle or tibia plateau and cul-
tured with or without anabolic or catabolic factors; without factors
(W/O), with either Oncostatin M [10ng/ml] combined with TNF-α
[20ng/ml] (O+T), or with IGF-1 [100ng/ml]. The cultures were kept
for 21 days, with medium change three times a week. The super-
natants were collected and stored at -20[[Unsupported Character
- &#8304;]]C until analysis in different assay.
ELISA 342-G2 and 374-G2 aggrecan biomarker assays were used
to test the aggrecan degradation. Moreover, markers of type I and
type II collagens were measured, including: CTX-I, PINP, CTX-II,
PIINP and several new markers of type II collagen.
Histology Safranin O and Fast Green staining were used to visu-
alize the morphology of the explants and evaluate potential signs
of OA-like pathological features. Collagen type X was used for the
biomarker of chondrocyte hypertrophy in full depth cartilage by
Immunohistochemstry.
Results: The alamarblue results showed that both W/O, O+T and
IGF-1 stimulated groups had good viability throughout the whole
culture period (21 days). Hydroxyproline release to the supernatant
from day 21 showed no differences between catabolic and anabolic
treatment. In contrast, the O+T group had more CTX-II fragment
released than the IGF-I group. Aggrecan fragment peak release
was at day 7 of 374-G2 (aggrecanase-mediated) and day 12 of
342-G2 (MMP -mediated), respectively. Type II collagen formation
(PIINP) was signiﬁcantly increased in response to IGF-1, whereas
PINP was not. The new degradation markers of type II collagen
were all released at late stages of the culture period. These
data was supported by histological assessment; GAG staining
was lost after 21 days of culturing with proinﬂammatory cytokines.
Furthermore the presence of type X collagen was more marked in
these catabolic stimulated explants.
Conclusions: We have developed an explant culture models that
include different subpopulations of chondrocytes as well as cal-
ciﬁed cartilage and subchondral bone. Here we have presented
the initial characterization of the model and shown that we can
stimulate the explants to a catabolic or anabolic phenotype. We
speculate that this characterized model could be used for investi-
gation of the effect of different compounds, as well as investigation
of cell-cell interaction between the cartilage and bone compart-
ment.
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FOXO TRANSCRIPTION FACTORS IN ARTICULAR
CHONDROCYTES
N. de Isla1, N. Charif1, C. Huselstein1, D. Bensoussan1,2,
J.-F. Stoltz1,2
1Nancy Université, UMR CNRS 7561, Vandoeuvre-lès-Nancy,
France; 2UTCT, CHU, Vandoeuvre-lès-Nancy, France
Purpose: This study was undertaken to examine the expres-
sion of FoxO transcription factors in human osteoarthritic articular
chondrocytes. Cellular localisation of these transcription factors
is regulated by de PI3K/AKT signaling pathway. Activated AKT
phosphorylated FoxO family members, which induces exclusion of
FoxO from the nucleus. Unphosphorylated FoxO proteins remain
actives in the nucleus and promote the transcription of genes that
regulate proliferation, apoptosis and stress resistance.
Methods: Human osteoarthritic articular chondrocytes were used
in this sudy. Interleukin-1B was used to stimulate chondrocytes
for 1 hour or 24 hours. The expression of FoxO family members
was assessed by western blotting. FoxO1, FoxO3a and FoxO4
localisation was performed by confocal microscopy and immuno-
histochemistry.
Results: Each of the 3 family members, FoxO1, FoxO3a, and
FoxO4, are expressed in human chondrocytes. FoxO3a expression
was found to be more important than FoxO1, whereas FoxO4
expression was very weak. In control cells, all three proteins were
found principaly in the nucleus of the cell ; with some proteins
found in the cytoplasm. Interleukin-1B effects on FoxO familly
members localisation were observed after 24 hours of stimulation,
whereas no obvious changes were observed after 1 hour. IL-1B
treatment for 24 hours induces a cytoplasmic localisation of the
FoxO transcription factors.
Conclusions: This study presents evidence that each of the 3
family members, FoxO1, FoxO3a, and FoxO4, are expressed in
osteoarthritic chondrocytes.
Results show that inﬂammatory extracellular stimulus, such as
IL-1B, was able to promote FoxO phosphorylation in human os-
teoarthritic chondrocytes in vitro. This phosphorylation induces
export of the FoxO proteins from the nucleus to the cytoplasm.
These transcription factors could participate in the regulation of
different phenomena found in the osteoarthritis pathology, like
apoptosis, chondrocyte proliferation, cell dediferentiation or resis-
tance to oxidative stress.
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FACTORS LOCALISATION ON HUMAN CHONDROCYTES
N. de Isla1, N. Charif1, J.-F. Stoltz1,2
1Nancy Université, UMR CNRS 7561, Vandoeuvre-lès-Nancy,
France; 2UTCT, CHU, Vandoeuvre-lès-Nancy, France
Purpose: The aim of this study was to investigate the effects of
diacerhein and rhein on FoxO transcription factors on human os-
teoarthritic chondrocytes. These transcription factors are involved
on the control of cell cycle progression, cell proliferation, induc-
tion of apoptosis and protection from oxidative stress ; and are
regulated by the PI3K/AKT transduction pathway.
